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. Infection with this organism, an intraerythrocytic parasite of the phylum Apicomplexa, causes a febrile syndrome similar to malaria 2 . Relapsing disease is common among immunocompromised and asplenic individuals 3, 4 and drug resistance has recently been reported 5 . To investigate the origin and genetic diversity of this parasite, we sequenced the complete genomes of 42 B. microti samples from around the world, including deep coverage of clinical infections at endemic sites in the continental USA. Samples from the continental USA segregate into a Northeast lineage and a Midwest lineage, with subsequent divergence of subpopulations along geographic lines. We identify parasite variants that associate with relapsing disease, including amino acid substitutions in the atovaquone-binding regions of cytochrome b (cytb) and the azithromycin-binding region of ribosomal protein subunit L4 (rpl4). Our results shed light on the origin, diversity and evolution of B. microti, suggest possible mechanisms for clinical relapse, and create the foundation for further research on this emerging pathogen.
Human babesiosis is a tick-borne zoonosis caused by piroplasms of the genus Babesia (Apicomplexa: Piroplasmida) 1 . In the USA, the vast majority of cases are due to Babesia microti, a parasite transmitted by Ixodes scapularis ticks and enzootic in the white-footed mouse, Peromyscus leucopus, and other small mammals 6 . Human infection occurs predominantly through the bite of an infected tick, but can also occur via transfusion of infected blood products 7 or transplacental passage 8 . The disease is characterized by fever and haemolysis, which, as in malaria, is thought to be a driving pathogenic process 9 . Infections range from asymptomatic to fulminant and can be complicated by respiratory failure, disseminated intravascular coagulation, or organ failure 10 . In historical series, death occurs in 3-5% of hospitalized patients 11, 12 and up to 20% of immunocompromised individuals 3 . In this latter population, prolonged parasitaemia and relapsing disease are common 3 , and resistance to first-line atovaquone/azithromycin therapy has recently been described 5 . Human infection with B. microti is reported in Europe 13 , Asia 14 and Australia 15 , but most cases occur in the USA, where there are foci in the Northeast (NE) and upper Midwest (MW) 1 . Since the first report of B. microti in the USA on Nantucket in 1969 16 , the geographic range 17, 18 and incidence 18, 19 have been increasing and the Centers for Disease Control and Prevention (CDC) now classifies human babesiosis as an emerging and nationally notifiable disease.
To gain insight into the evolution, geographic expansion and drug resistance of B. microti, we sequenced the complete genomes of 42 samples, including 32 human cases, two samples from ticks and four from rodents (Fig. 1a, b and Supplementary Table 1) . We sequenced the 6.4 Mb genome to a mean depth of 153-fold on Illumina HiSeq instruments using a paired-end protocol. Among the 39 B. microti sensu stricto samples (BMSS-see Supplementary Section 'Nomenclature and geographic grouping' for a glossary of geographic terms), we identified a total of 114,336 single nucleotide polymorphisms (SNPs), approximately 1 per 56 bases (see Methods).
We first examined the origin of B. microti. We established a rooted phylogeny for our cohort using concatenated COX1-CYTB-COX3 mitochondrial protein sequences with Babesia rodhaini as an outgroup (Fig. 1c) . This analysis confirmed the extensive worldwide diversity and polyphyletic nature of B. microti in the USA, with the Alaskan sample separated from the continental USA (CUS) lineages with Russian and Japanese samples intervening. Within BMSS, the Russian sample is distinct from, and basal to, samples from CUS.
We next used the genomic data to establish the phylogeny of CUS strains with the Russian sample as the outgroup. This revealed a structured CUS epidemic with deep divergence between NE and MW samples ( Fig. 1d and Supplementary Fig. 3 ). In the NE group, there were three subpopulations (Fig. 1d) , labelled here as NAN (Nantucket), MNE (mainland New England) and REF (R1 reference group). The MNE lineage in our data set typed with the Connecticut/Rhode Island lineage reported previously 20 . A single sample from North Dakota grouped with the MNE strains. As the travel history was not available for this patient, we cannot establish whether this was an imported or autochthonous case. We identified one case of probable locally imported babesiosis from Nantucket to South Dennis, MA (see Supplementary Section 'Possible evidence for locally imported babesiosis in Bab14'). NE populations had minimal nucleotide diversity π (3.1 × 10 −6 to 6.1 × 10 −6 ) and strong population differentiation (Wright's fixation index F ST = 0.95-0.96; Table 1 and Supplementary Fig. 4a,b) , indicating small, geographically isolated and inbred populations. Most of the variation separating the MNE lineage from the NAN lineage was found in two segments of chromosome 2, segments in which both lineages also share an unusually large amount of variation with MW strains (see Supplementary Section 'Discordant loci on chromosome 2'). We found evidence of recombination among CUS as a set, but not within individual NE lineages ( Supplementary Fig. 5 ). The MNE lineage demonstrated evidence of recent population expansion, with strongly negative values throughout the genome for Tajima's D and other statistics of neutral evolution (Table 1 and Fig. 2b ), consistent with epidemiological data 18 . We did not detect a significant relationship between D and π ( Supplementary Fig. 4c,d ). Longitudinal sampling of MNE and NAN samples demonstrated evidence of an empirical molecular clock ( Supplementary Fig. 6a,b) . Using Bayesian evolutionary analysis of sampling trees (BEAST) 21 , we estimated the time to most recent common ancestry (TMRCA) for the CUS lineages (Fig. 3b) . MNE, REF and NAN all emerged within the last 600 years, but the TMRCA for CUS was much earlier, between 1,350 and 14,700 years (95% highest posterior density (HPD), median of 5,043 years), under the best-supported uncorrelated exponential distribution (UCED) model (see Supplementary Section 'Time to most recent common ancestry'). We next examined evidence for genome evolution. The density of variants was uniform throughout the genome (Fig. 2a) , except in subtelomeric and select intrachromosomal regions, where numerous substitutions were detected (Supplementary Fig. 7a and Supplementary Table 3 ). In this respect, the structure of the B. microti genomic diversity resembles that of many other parasites and bacteria (Supplementary Section 'Multi-copy gene families and genomic distribution of variants'). We calculated the dN/dS ratios for all protein coding genes between Russian and US B. microti (Supplementary Fig. 8 and Supplementary Table 4 ). Most proteins demonstrated strong evidence of purifying selection (mean = 0.21 ± 0.41), particularly those encoded by the mitochondrial genome (adjusted P = 8.8 × 10 −6 , 1.6 × 10 −3 and 1.2 × 10 −2 for cox1, cytochrome b (cytb) and cox3, respectively; see Methods). We found significant positive selection in only a single gene, BBM_I00435 (adjusted P = 0.036), of unknown function (Supplementary Table 4 ). Among four additional hits with adjusted P < 0.1, two (BBM_I03535 and BBM_I00004) were BMN genes, a sero-reactive gene family located at chromosome ends and hypothesized to play a role in immune evasion 22 . As a family, BMN genes showed evidence of positive selection (P = 1.9 × 10 −6 ; Wilcoxon rank sum test) and an elevated substitution rate ( Supplementary  Fig. 8e ,f ). Our cohort included five cases of relapsing babesiosis (Bab05, Bab14, MGH2001 4 , BWH2003 and MORNS2015), which were studied out of concern that they harboured a resistant phenotype after failing drug treatment. To search for genes that may be involved in relapse, we first inspected the non-synonymous variants that separated each relapsing case from its nearest, non-relapsing neighbour (Supplementary Table 7) , a small set due to the limited genetic diversity within a given lineage. All five cases contained non-synonymous variants in cytochrome b and three out of five contained variants in rpl4, exceeding the number expected due to chance (adjusted P = 3.9 × 10 −13 for cytb, 1.3 × 10 −4 for rpl4, Fig. 4a ; see Methods). Zero variants were observed in non-relapsing cases from lineage-matched (MNE and NAN) controls (adjusted P = 0.01 for cytb, Fisher's exact test; adjusted P = 1 for rpl4; unadjusted P = 5.6 × 10 −3 , the second-strongest signal of association after cytb, Supplementary Fig. 9 ).
Cytochrome b is the known target of atovaquone in other Apicomplexa (Fig. 4b ) 23 . CYTB is a highly conserved mitochondrial Table 8) are also indicated. c, Variants in RPL4 associated with relapse in B. microti are shown as in b. Also shown are variants associated with azithromycin resistance in P. falciparum (P) 26 S. pneumoniae (S) 30 and E. coli (E) 28 .
LETTERS NATURE MICROBIOLOGY DOI: 10.1038 /NMICROBIOL.2016 protein under strong purifying selection (adjusted P = 1.6 × 10 −3 ). The identified amino acid changes occur in the atovaquonebinding regions of cytochrome b and resemble the atovaquone resistance mutations observed in other parasites ( Fig. 4b and Supplementary Fig. 10 ). The M134I substitution observed in MGH2001 has been studied in the Plasmodium falciparum CYTB orthologue and results in a 25-fold decrease in susceptibility to atovaquone in P. falciparum 24 (Supplementary Table 8 ). This variant has also been associated with relapsing canine babesiosis due to Babesia gibsoni 25 . The L277P variant was present in two relapsing cases (Fig. 4b and Supplementary Table 7) , despite its absence in phylogenetically intermediate samples, suggesting adaptive evolution. Together, these findings suggest that mutations in cytb may promote relapse by decreasing atovaquone binding.
We next considered mutations in rpl4, a subunit of the 50S ribosome encoded in the apicoplast genome. Two relapsing cases contained substitutions in the same codon, arginine 86 (R86H in Bab05 and R86C in Bab14) , which is highly conserved across multiple bacteria and parasites (Fig. 4c) . One of these cases, Bab05, presented with a severe relapse while on azithromycin monotherapy (Supplementary Section 'Clinical details of relapsing cases' and Supplementary Fig. 9c) , indicating high-level clinical azithromycin resistance. The mutated arginine is three residues C-terminal to G83, the codon that mediates azithromycin resistance in P. falciparum (Fig. 4c ) 26 and adjacent to the azithromycin binding pocket of the 50S ribosomal pore, the site of azithromycin resistance in multiple species of bacteria (Supplementary Fig. 11 and Supplementary Table 8) 27, 28 . A third relapsing case (MORNS-2015) was found to have an S73L substitution, and during manual re-examination of the locus, a fourth relapsing case (BWH2003) was also found to contain a C103Y variant in 28/74 reads. These results suggest that mutations in rpl4 may promote relapse by diminishing azithromycin susceptibility.
In summary, we have characterized the emergence of B. microti in the USA and identified variants in cytb and rpl4 that associate with relapsing babesiosis. CUS strains show strong geographic structure, possess minimal diversity as a group, and differ greatly from their nearest neighbour, a Russian strain. North American B. microti is polyphyletic, suggesting at least two introductions into the subcontinent. The rarity of interbreeding and timing of divergence are consistent with proposed models of allopatric speciation due to glaciation 6 . The genes under positive selection between US and Russian B. microti are candidates for investigations of how this parasite adapts to new environments or acquires virulence. Despite considerable evolutionary distance, B. microti appears to share principles of genomic organization and mechanisms of drug resistance with other parasitic protozoa. These commonalities may prove useful in understanding mechanisms of virulence and in developing new therapies against this class of pathogens.
Methods
Short read alignment and variant detection. We aligned short reads to the B. microti R1 reference genome using bwa mem 31 . The original R1 reference contained chromosome 3 as a supercontig of chromosomes 3 and 4. We obtained the revised versions of chromosome 3 (GI: 908660426) and 4 (GI:908661396) from Genbank, which we incorporated into a new reference genome, together with the annotated apicoplast sequence (GI:658131431) and isoform I of the mitochondrion (GI:908661431). Variants were called using the UnifiedGenotyper tool from the Genome Analysis ToolKit (GATK) 32 with best practices and with the ploidy set equal to 1 and a minimum quality score of 50 for SNPs. To establish a set of high-confidence variants, we filtered the identified variants to require each variant to be supported by >70% of the reads aligning at that position using a custom python script. We considered variants as present or absent. This assumes clonality or near-clonality of infection. We tested this assumption by examining the distribution of the proportion of reads supporting the alternate allele ( Supplementary Fig. 1g,h) , which was close to or equal to 1 in nearly all cases. The number of variants in each gene was counted using R and functions from the Biostrings package 33, 34 . P values for substation rate were calculated using a one-sample, two-tailed Z test of location for each gene. Short reads for all samples sequenced in this study are freely available in the European Nucleotide Archive under accession code PRJEB13263.
Population genetic analysis. We used R to calculate population genetic summary statistics. We performed principal component analysis using the MDSscale() function. We used the PopGenome package 35 to calculate nucleotide diversity, Wright's fixation index and neutrality statistics and to compute population genetic summary statistics in sliding windows. Geographic data were plotted in R using the package rworldmap 36 . Serial replicates of strains propagated in rodent models (later timepoints of GI and RMNS) were excluded from population genomic studies, the calculation of population summary statistics and BEAST analysis (as described below), as were identical strains felt to represent possible stock contamination (Gray and Peabody strains; Table 1 ). dN/dS ratios were calculated using the kaks() function in SeqinR 37 . P values for dN/dS ratios were calculated for each gene from the standard normal with test statistic Z = (dN -dS)/sqrt(var(dS) + var(dN)) and a two-tailed test.
Phylogenetic analysis. For mitochondrial protein sequence analysis, we downloaded the Genbank sequences of B. rodhaini (AB624357.1) and extracted the mitochondrial sequences from the mitochondrial proteins of B. microti sequenced in this analysis. For global B. microti isolates, we obtained this sequence from translated mitochondrial fragments (as identified by Promer, as below) using Artemis 38 . For CUS isolates, given minimal sequence variability, we called variants as above and then, using Artemis, extracted the mitochondrial gene sequence based on the R1 annotation coordinates. Concatenated COX1, CYTB and COX3 protein sequences were aligned using MUSCLE 39 and then analysed in BEAST v1. 8.1 (ref. 21) . Alignments were visualized in JalView 40 , which was also used to colour residues by physicochemical properties. For whole-genome phylogenetic inference, after calling variants as described above, we created an alignment using the FastaAlternateReferenceMaker from the GATK. Sites at which we lacked the coverage to make a definitive call in all samples were considered invariant and defaulted to the reference. For all samples, greater than 99% of the genome was covered by two or more reads (Supplementary Fig. 2b ). We excluded serial replicates of strains cultivated in rodent models (that is, GI and RMNS). Root-to-tip analysis was performed in Path-O-Gen (http://tree.bio.ed.ac.uk/software/pathogen/) using the best-fit root on a maximum-likelihood tree inferred in RAxML version 8 (ref. 41) , with sample collection dates for the tip dates. Given the unusual ancestry of portions chromosomes 2 (see below), analysis in Path-O-Gen and BEAST was performed on alignments with chromosome 2 excluded. For tip dates, we used the date of genomic DNA isolation, except for the Gray and Peabody strains, for which we used date of collection (1969 and 1973) as these were obtained from ATCC and minimally propagated in our hands. These genomes were identical and possibly represent contamination of one stock with another. We treated them as a single strain with a date of 1971 and uncertainty of ±2 years in the BEAST and Path-O-Gen analysis. The reference isolate was assigned a tip date of 2005 ± 5 years as the date of collection was not available in ref. 42 . Regression models were fit in R. The geographic location of samples, when available, was assigned from the location of collection (ticks and historical laboratory isolates), or the town of residence for patients who enrolled in the consented protocol (see section 'Collection of clinical samples'). For discarded clinical specimens, the location of the hospital of collection is labelled in Fig. 1b .
Testing for variants associated with relapse. To construct Supplementary Table 7 , the nearest neighbour of each relapsing case was first determined by minimum p-distance. The number of non-synonymous variants was identified by calculating the string distance of the translated genomic sequence to that of the nearest neighbour using Biostrings 33 in Bioconductor
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. To test whether genes demonstrated excess substitution, we calculated a background rate of non-synonymous substitution for non-synonymous sites among nearest neighbours by counting the number of pairwise non-synonymous variants between nearest neighbours for relapsing as well as non-relapsing cases within MNE and NAN lineages. If a given sample had more than one nearest neighbour, only the first comparison (defined as the initial pairwise comparison for a given sample in the alphabetically ordered list of samples in the directory) was included to avoid redundant comparisons (results without this correction were essentially unchanged: using all pairwise comparisons, adjusted P = 2.04 × 10 −13 for cytb and 9.3 × 10 −5 for rpl4). The mean number of non-synonymous variants was then divided by the total number of non-synonymous sites in the B. microti genome, counted using the method of Nei and Gojobori 43 . We then tested whether the rate for each gene was equal to this background rate under a Poisson model. Apicoplast proteins appeared to accumulate non-synonymous variants at an increased rate ( Supplementary Fig. 8 , P = 9.8 × 10
, Wilcoxon rank sum test), with a mean of 2.0-fold the number of non-synonymous variants as compared to nuclear genes ( Supplementary Fig. 8 ). We therefore adjusted the background rate by a factor of 2.0 for apicoplast genes in these tests. Mitochondrial variants accumulated variation at a reduced rate (mean of 0.66-fold), but this was not significant (P = 0.44, Wilcoxon rank sum test) and we therefore did not adjust the background rate for mitochondrial comparisons. UMMS1-5, SN-1988 and PI-2000 had minimal coverage of apicoplast sequences and were excluded from this analysis. We also applied Fisher's exact test to the number of relapsing and lineage-matched non-relapsing cases with non-synonymous mutations identified. For all approaches, P values were adjusted for multiple comparisons using the method of Benjamini and Hochberg 44 .
Structural modelling of mutations. The Saccharomyces cerevisiae cytochrome bc1 complex (PDB: 4PD4) 45 and Thermus thermophilus ribosomal protein L4 (ref. 46 ; PDB: 4V7Y, bundle 2) crystal structure coordinates were acquired from the Protein Data Bank (http://www.rcsb.org) and viewed using Mac Pymol (Schrodinger). Residues were mutated as indicated in the figure legends using the Pymol Mutagenesis wizard and selecting for rotamers with the highest likelihood of occurrence based on backbone-restrained rotamer probabilities.
Whole genome assembly. We used ABySS (ref. 47) with k set to 60 to perform de novo assemblies of B. microti sensu lato isolates from Alaska and Japan. We aligned the resulting contigs to the B. microti reference genome using Promer as implemented in MUMmer3. 23 (ref. 48) . Draft assemblies are available in Supplementary Datasets 1-3 .
Code availability. The computer code used to generate results is provided in Supplementary Dataset 8.
Collection of clinical samples. We identified patients through the Massachusetts General Hospital (MGH) microbiology laboratory and at the University of Massachusetts Medical School (UMMS). At MGH and Brigham and Women's Hospital (BWH), we obtained informed consent according to Partners IRB protocol 2014P000948 and collected a venous blood sample of 5-10 ml in a heparin tube at the time of enrolment, storing it at 4°C for less than 3 weeks. Patients with a positive Babesia smear or B. microti PCR test were eligible for the study. Exclusion criteria included pregnancy, age under 18 years and specific vulnerable populations (medical students and prisoners). We extracted DNA from infected red blood cells (RBCs) after cellulose filtration as described below. In some cases, where patients were hospitalized briefly or we were unable to approach them for participation in this study, we used parasite-only material as IRB-exempted de-identified discarded specimens, but only in cases where we were unable to contact the patient. At UMMS, IRB-exempted de-identified discarded peripheral blood samples were obtained from the hospital clinical laboratory. Historical laboratory-adapted strains and tick samples were obtained from Tufts School of Veterinary Medicine. Serial isolates of the GI strain were grown continuously with recurrent tick and rodent passage from 1986 to 2014 (Supplementary Table 1 ). The RMNS strain was maintained in a similar manner but frozen intermittently for brief periods between 1997 and 2001. Historical samples were obtained from The Mayo Clinic as discarded, de-identified specimens.
Isolation of B. microti-infected RBC. For patient samples obtained at MGH that underwent cellulose enrichment, we filtered 1-5 ml of venous blood through a filter consisting of a 5 cm cellulose (Sigma P/N# C6288-100G) column in a 10 ml syringe. The filtrate contained infected and uninfected RBCs, whereas human leukocytes were retained in the column. Giemsa staining of the flow-through confirmed leukocyte depletion. Historical strains of B. microti were propagated in adult Golden Syrian hamsters (Mesocricetus auratus; 40-50 g, 3-4 weeks old) from Charles River Laboratories. For these strains and some patient samples collected as described above, we directly sequenced DNA extracted from whole blood without leukocyte depletion. All animal work was performed under approved protocols from the Laboratory of Animal Medicine Services at Tufts School of Veterinary Medicine. Patient samples had parasitaemia between 0.1 and 20%. For these, cellulose filtration or hybrid selection enriched the ratio of parasite to host nucleic acid, yielding an average enrichment of 4.9-fold ( Supplementary Fig. 1a ).
Genomic DNA preparation. We used Qiagen DNEasy kit (Qiagen P/N#69504) to extract genomic DNA. We added a volume of 200 μl whole blood to each reaction according to the manufacturer instructions and pooled DNA from two to four extractions to generate enough material for sequencing.
Sequencing. We performed DNA sequencing at the Broad Institute and UMMS on an Illumina HiSeq instruments. For libraries sequenced at the Broad Institute, we sheared 100 ng to 1 μg purified genomic DNA on a Covaris S220 instrument to a mean fragment size of 400 base pairs. The total shearing time was 1 min 12 s, made up of 6 cycles of 9 s each. Peak power was 140.0, with a duty factor of 10.0, and cycle/burst of 200. Samples were held at ∼6°C. We then performed library construction on an IntegenX Apollo 324 robot according to the PrepX 320 base pair library preparation. During library construction, we added 6 bp NEXTFlex adapters (BioO Scientific P/N#514102) so that up to 12 samples could be sequenced per lane. For quality control, quantification and sizing, we ran the completed library material on an Agilent Bioanalyzer with a High Sensitivity DNA kit (Agilent P/N#5067-4627). Libraries were pooled at a minimum concentration of 2 nM and sequenced on HiSeq instruments. When library concentration was inadequate for sequencing, we amplified the finished libraries with six to eight cycles of PCR using an NEB polymerase (NEBNext High-Fidelity 2x PCR Master Mix P/N#M0541S and NEXTFlex DNA-PCR Primer Mix).
For libraries sequenced at UMMS, we sheared 100 ng to 1 μg purified genomic DNA on a Covaris S2 instrument to a mean fragment size of 300 base pairs. We then performed library construction according to standard TruSeq protocols, with the substitution of indexed NEXTFlex adapters.
Hybrid selection Agilent SureSelect. We developed a custom Agilent SureSelect developer hybrid selection library containing sequencings for known Ixodes scapularis pathogens, including Babesia microti, Borrelia burgdorferi, Borrelia miyamotoi, Anaplasma phagocytophilum and Powassan Virus. The nucleotide sequences provided to Agilent for fabrication of the SureSelect library are provided in Supplementary Dataset 4. We performed hybrid selection according to the manufacturer's protocol with six to eight cycles of amplification before hybrid selection and 10-12 cycles of amplification afterwards, according to the above protocol. Libraries were prepared on the Apollo as already described.
Whole genome bait. Whole blood (2 ml) was collected over sodium heparin from B. microti-infected rag-deficient C57BL/6J laboratory mice housed at Tufts Medical Center. At UMMS, blood was then subjected to centrifugation with Lympholyte-M (Cedarlane). Genomic DNA was extracted from erythrocyte-enriched fractions using the QIAmp DNA Mini Kit (Qiagen). This DNA (100 ng) was amplified using the Genomiphi V3 kit (GE). Whole genome-amplified product (5 μg) was used as input to prepare DNA templates for biotinylated RNA baits according to a protocol modified from ref. 49 . Input DNA was sheared for 280 s on a Covaris S2 instrument set to a duty factor of 10%, an intensity of 5, and 200 cycles per burst to obtain a fragment size distribution with a mode of ∼150 base pairs. End repair, 3′ adenylation and adapter ligation were performed according to the Illumina genomic DNA sample preparation kit protocol, with the exceptions of using the adapter oligonucleotides (IDT) specified by Melnikov et al. 49 rather than Illumina kit adapters and cleaning reactions after each step using 1.8× volume AMPure XP beads (Beckman Coulter). Cleaned ligation products were amplified by 8-14 cycles of PCR in Q5 HF buffer (NEB) using forward and reverse PCR primers (IDT) from Melnikov and co-authors 49 . Initial denaturation was 30 s at 98°C, and each cycle was 10 s at 98°C, 30 s at 55°C and 30 s at 72°C. PCR products were size-selected on a 1.5% agarose gel followed by MinElute gel extraction (Qiagen). Gel-purified PCR products were re-amplified as above using the T7 promoter-containing forward primer (IDT) from ref. 49 . AMPure XP-cleaned PCR product (300 ng) was used as a template to prepare biotinylated RNA baits in a 25 μl MEGAscript T7 transcription (Ambion) containing 7.5 mM ATP, 7.5 mM CTP, 7.5 mM GTP, 5.625 mM UTP and 1.875 mM Biotin-16-UTP (Roche). After 18 h at 37°C, Turbo DNase (Ambion) was added to the reaction to remove the DNA template. Unincorporated nucleotides were removed by cleaning with 1.8× volume reaction RNAclean AMPure XP beads (Beckman Coulter). Cleaned baits were stored in the presence of 1 U μl -1 SUPERase-In RNase inhibitor (Ambion) at −80°C. The yield was typically 10-20 μg of biotinylated RNA as determined by an RNA 6000 Nano Bioanalyzer assay (Agilent).
Hybrid selection was conducted as described by Gnirke and co-authors 50 . For each whole genome fragment library prepared with indexed Nextflex paired-end adapter sequences (BioO Scientific) from a B. microti-infected diagnostic sample, a 250 μl 'pond' library was hybridized with 500 ng of whole genome bait at 65°C for 72 h in a 13 μl reaction volume, with all components besides baits scaled down proportionately from Gnirke and co-workers 50 . Captured DNA was pulled down using 250 ng (25 μl) MyOne Streptavidin T1 Dynabeads (Invitrogen). Beads were then washed at room temperature for 15 min in 250 μl/0.5 ml 1 × SSC/0.1% SDS, followed by three 10 min washes at 65°C with 250 μl 0.1 × SSC/0.1% SDS pre-warmed to 65°C. Beads were incubated with 25 μl 0.1 M NaOH for 10 min at room temperature to elute selected DNA. Eluate was subsequently transferred to a tube containing 35 μl 1 M Tris-HCl, pH 7.5 and desalted and concentrated by clean-up with AMPure XP beads. The hybrid-selected library was amplified for 10-14 cycles in Q5 HF buffer using Nextflex genomic library primers. Initial denaturation was 30 s at 98°C, followed by cycles of 10 s at 98°C, 30 s at 65°C and 30 s at 72°C. AMPure XP-cleaned PCR product was quantified using qPCR in Power SYBR Green master mix (Life) and NEXTFlex primers. Four indexed, hybrid-selected libraries were sequenced with one lane of Illumina HiSeq 100 bp paired-end reads at UMMS.
Quantitative PCR. Before sequencing, parasite DNA enrichment was assessed using a qPCR primer set designed to amplify the B. microti-specific amplicon within the gene BBM_III07585 in the B. microti reference genome. Each Power SYBR Green qPCR reaction contained 5 ng pre-or post-selection library as quantified by Quant-iT PicoGreen dsDNA assay kit (Life). Oligonucleotide sequences were from Melnikov and co-authors 49 . B. microti qPCR primer Amplicon Chr 3 (GenBank FO082874.1): gene BBM_III07585. Forward primer: 5′-GGTTCCCTAATGGAGACCCTACTA-3′. Reverse primer: 5′-GGCGCCCTTCTTTAAATCCA-3′.
Accession codes. Sequence reads are available at the European Nucleotide Archive under accession code PRJEB13263.
